The Immunologic System

  • Robert D. Gillette
  • James V. Lustig
Chapter

Abstract

The immune mechanism protects the host from a hostile environment by destroying invading organisms and rejecting foreign cells and substances. It may also cause tissue damage and untoward symptoms in the host. Diseases that are mediated by such maladaptive immune responses are termed “allergies” (G. allos, other, + ergon, work). Each of these conditions has its genesis in the ingestion, inhalation, injection, or absorption through the skin of a substance that is perceived by the body as foreign. Recent advances in immunology have led to a much wider conceptualization of the immune response and its consequences,1 but it is still clinically useful to group together diseases caused by immunologic hyperreactivity to exogenous antigens and to speak of them as “allergic.”

Keywords

Food Allergy Allergic Rhinitis Allergy Clin Immunol Acquire Immune Deficiency Syndrome Acute Asthma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Swineford O. Allergy versus clinical immunology: a critical analysis. Ann Allergy 1974; 33: 262–266.PubMedGoogle Scholar
  2. 2.
    Chang WWY. Pollen survey of the United States. In: Patterson R, ed. Allergic diseases: diagnosis and management. 2d ed. Philadelphia: Lippincott, 1980: 148–178.Google Scholar
  3. 3.
    Roth A. Allergy in the world. Honolulu: University Press of Hawaii, 1978.Google Scholar
  4. 4.
    Settipane GA, Chaffee FH. Nasal polyps in asthma and rhinitis. J Allergy Clin Immunol 1977; 59: 17–21.PubMedCrossRefGoogle Scholar
  5. 5.
    Orgel HA, Kemp JP, Meitzer EO, et al. Atopy and IgE in a pediatric allergy practice. Ann Allergy 1977; 39: 161–168.PubMedGoogle Scholar
  6. 6.
    Adkinson NF. The radioallergosorbent test: uses and abuses. J Allergy Clin Immunol 1980; 65: 1–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Rasmuson M, Collinder E, Henschen-Edman A, et al. Allergic reaction patterns in relation to age, sex, season, eosinophilia and some genetic marker systems. Acta Allergol 1973; 28: 365–400.PubMedCrossRefGoogle Scholar
  8. 8.
    Voorhorst R, vanKrieken H. Atopie skin test reevaluated. II. Variability in results of skin testing done in octuplicate. Ann Allergy 1973; 31: 499–508.PubMedGoogle Scholar
  9. 9.
    Zwemer RJ, Karibo J. Use of laminar control device as adjunet to Standard environmental control measures in symptomatic asth-matic children. Ann Allergy 1973; 31: 284–290.PubMedGoogle Scholar
  10. 10.
    Lichtenstein LM, Valentine MD, Sobotka AK. Insect allergy: the State of the art. J Allergy Clin Immunol 1979; 64: 5–12.PubMedCrossRefGoogle Scholar
  11. 11.
    Collins-Williams C. The status of immunotherapy in children— what are the problems? Ann Allergy 1977; 39: 87–93.PubMedGoogle Scholar
  12. 12.
    VanMetre TE, Adkinson NF, Amodio FJ, et al. A comparative study of the effectiveness of the Rinkel method and the current Standard method of immunotherpay for ragweed pollen hay fever. J Allergy Clin Immunol 1980; 66: 500–513.CrossRefGoogle Scholar
  13. 13.
    Solley GO. Present status of immunotherapy (desensitization) for allergic disorders. South Med J 1979; 71: 183–188.CrossRefGoogle Scholar
  14. 410.
    Robert D. Gillette and James V. LustigGoogle Scholar
  15. 14.
    Patterson R, Lieberman P, Irons JS, et al. Immunotherapy. In:Google Scholar
  16. Middleton E, Reed CE, Ellis EF, eds. Allergy: principles and practice. St. Louis: Mosby, 1978; 877–898.Google Scholar
  17. 15.
    Luparello TJ, McFadden ER, Lyons HA, Bleecker ER. Psychological factors and bronchial asthma: laboratory model for investi-gation. NY State J Med 1971; 71: 2161–2165.Google Scholar
  18. 16.
    Mattsson A. Long-term physical illness in childhood: a challenge to psychosocial adaptation. Pediatrics 1972; 50: 801–811.PubMedGoogle Scholar
  19. 17.
    McNichol KN, Williams HE, Allan J, et al. Spectrum of asthma in children. III. Psychological and social components. Br Med J 1973; 4: 16–20.PubMedCrossRefGoogle Scholar
  20. 18.
    Berrens L. Inhalant allergens in human atopic disease: their chem-istry and modes of action. Ann NY Acad Sei 1974; 221: 183–198.CrossRefGoogle Scholar
  21. 19.
    Broder I, Higgins MW, Mathews KP, et al. Epidemiology of asthma and allergic rhinitis in a total Community, Tecumseh, Michigan. IV. Natural history. J Allergy Clin Immunol 1974; 54: 100–110.PubMedCrossRefGoogle Scholar
  22. 20.
    Blue JA. Current concepts of allergy of the eye. Ann Allergy 1974; 33: 267–273.PubMedGoogle Scholar
  23. 21.
    Gorenberg D. Rhinitis medicamentosa. West J Med 1979; 131: 313.PubMedGoogle Scholar
  24. 22.
    VanArsdel PP. Diagnosing drug allergy. JAMA 1982; 247: 2576–2581.CrossRefGoogle Scholar
  25. 23.
    McQueen EG. Pharmacological basis of adverse drug reactions. In: Avery GS, ed. Drug treatment: principles and practice of clinical pharmacology and therapeutics. New York: Adis Press, 1980.Google Scholar
  26. 24.
    Arndt KA, Jick H. Rates of cutaneous reactions to drugs. JAMA 1976; 225: 918–922.CrossRefGoogle Scholar
  27. 25.
    Jenner GG, Macintosh D, West SR, et al. Intensive monitoring of adverse reactions in general practice. NZ Med J 1976; 83: 378–379.Google Scholar
  28. 26.
    Schatz M, Patterson R, O’Rourke J, et al. The administration of radiographic contrast media to patients with a history of previous reaction. J Allergy Clin Immunol 1975; 55: 358–366.PubMedCrossRefGoogle Scholar
  29. 27.
    McNichol KN, Williams HE. Spectrum of asthma in children—I. Clinical and physiological components. Br Med J 1973; 4: 7–11.CrossRefGoogle Scholar
  30. 28.
    Froom J. Prevalence and natural history of chronic diseases in childhood. In: Grave GD, Pless IB, eds. Chronic childhood illness: assessment of outcome. DHEW Publ. No. 76–877. Bethesda MD: NIH, 1976.Google Scholar
  31. 29.
    Kuzemko JA: Natural history of childhood asthma. J Pediatr 1980; 97: 886–892.PubMedCrossRefGoogle Scholar
  32. 30.
    Busse WW: The preeipitation of asthma by Upper respiratory infections. Chest 1985; 87 (1, Suppl): 44S - 48S.PubMedCrossRefGoogle Scholar
  33. 31.
    ACCP-ATS Joint Committee on Pulmonary Nomenclature. Pulmonary terms and symbols. Chest 1975; 67: 583–593.CrossRefGoogle Scholar
  34. 32.
    Beers RF. Diseases which simulate allergy. Med Clin North Am 1974; 58: 207–231.PubMedGoogle Scholar
  35. 33.
    Cloutier MM, Loughlim GM. Chronic cough in children: a mani-festation of airway hyperreactivity. Pediatrics 1981; 67: 6–12.PubMedGoogle Scholar
  36. 34.
    Barnes P, FitzGerald G, Brown M, et al. Nocturnal asthma and changes in circulatory epinephrine, histamine, and Cortisol. N Engl J Med 1980; 303: 263–267.PubMedCrossRefGoogle Scholar
  37. 35.
    Cohen SH. Advances in the diagnosis and treatment of asthma: clinical evaluation—allergy and immunology. Chest 1985; 87 (1, Suppl): 26S - 29S.PubMedCrossRefGoogle Scholar
  38. 36.
    Lulla S, Newcomb RW. Emergency management of asthma in children. J Pediatr 1980; 97: 346–350.PubMedCrossRefGoogle Scholar
  39. 37.
    Williams MH. Evaluation of asthma. Chest 1979; 76: 3–4.PubMedCrossRefGoogle Scholar
  40. 38.
    Weinberger M, Hendeles L. Slow-release theophylline: rationale and basis for produet selection. N Engl J Med 1983; 308: 760–764.PubMedCrossRefGoogle Scholar
  41. 39.
    Cummiskey JM, Popa V. Theophyllines—a review. J Asthma 1984; 21: 243–257.PubMedCrossRefGoogle Scholar
  42. 40.
    Lotner GZ, Vanderpool GE, Carroll S, Tinkelman DG, Spangler DL. Bioavailability of sustained-release theophylline granules in apple sauce in pediatric asthmatic patients. Ann Allergy 1983; 50: 27–29.PubMedGoogle Scholar
  43. 41.
    Uden DL, Goetz DR, Kohen DP, Fifield GC. Comparison of neb-ulized terbutaline and subeutaneous epinephrine in the treatment of acute asthma. Ann Emerg Med 1985; 14: 229–232.PubMedCrossRefGoogle Scholar
  44. 42.
    Nelson HS. Stepwise therapy of bronchial asthma: the role of beta-adrenergic agonists. Ann Allergy 1985; 54: 289–293.PubMedGoogle Scholar
  45. 43.
    Loren ML, Chai H, Leung P, et al. Corticosteroids in the treatment of acute exaeerbations of asthma. Ann Allergy 1980; 45: 67–71.PubMedGoogle Scholar
  46. 44.
    Wyatt R, Waschek J, Weinberger M, et al. Effects of inhaled beclomethasone dipropionate and alternate-day Prednisone on pi-tuitary-adrenal function in children with chronic asthma. N Engl J Med 1978; 299: 1387–1392.PubMedCrossRefGoogle Scholar
  47. 45.
    Godfrey S. The relative merits of Cromolyn sodium and high-dose theophylline therapy in childhood asthma. J Allergy Clin Immunol 1980; 65: 97–104.PubMedCrossRefGoogle Scholar
  48. 46.
    Lustig JV, Groothuis JR. Childhood asthma: considerations in establishing treatment programs. Primary Care 1984; 11(3)453–468.Google Scholar
  49. 47.
    Gauthier Y, Fortin C, Drapeau P, et al. The mother-child relationship and the development of autonomy and self-assertion in young (14–30 months) asthmatic children. J Am Acad Child Psychiatry 1977; 16: 109–131.PubMedCrossRefGoogle Scholar
  50. 48.
    Parcel GS, Gilman SC, Nader PR, et al. A comparison of absentee rates of elementary school children with asthma and nonasthmatic schoolmates. Pediatrics 1979; 64: 878–881.PubMedGoogle Scholar
  51. 49.
    Horton DJ, Suda WL, Kinsman RA, et al. Bronchoconstrictive suggestion in asthma: a role for airways hyperreactivity and emotions. Am Rev Respir Dis 1978; 117: 1029–1038.PubMedGoogle Scholar
  52. 50.
    Mattsson A. Psychological aspects of childhood asthma. Pediatr Clin North Am 1975; 22: 77–88.PubMedGoogle Scholar
  53. 51.
    Creer TL. Asthma therapy: a behavioral health care system for respiratory therapy. New York: Springer, 1979.Google Scholar
  54. 52.
    Hindi-Alexander M, Cropp, GJA. Community and family programs for children with asthma. Ann Allergy 1981; 46: 143–148.PubMedGoogle Scholar
  55. 53.
    Gordon M, Niswander KR, Berendes H, et al. Fetal morbidity following potentially anoxigenic obstetric conditions. VII. Bronchial asthma. Am J Obstet Gynecol 1970; 106: 421–429.PubMedGoogle Scholar
  56. 54.
    Greenberger PA, Patterson R. Management of asthma during pregnancy. N Engl J Med 1985; 312: 897–902.PubMedCrossRefGoogle Scholar
  57. 55.
    Melbye M. The natural history of human T lymphotropic virus-III infection: the cause of AIDS. Br Med J 1986; 292: 5–12.CrossRefGoogle Scholar
  58. 56.
    Petricciani JC. Licensed tests for antibody to human T-lympho-trophic virus type III. Ann Intern Med 1985; 103: 726–729.PubMedCrossRefGoogle Scholar
  59. 57.
    Hardy AM, Allen JR, Morgan WM, Curran JW. The incidence rate of acquired immunodeficiency Syndrome in selected popula-tions. JAMA 1985; 253: 215–220.PubMedCrossRefGoogle Scholar
  60. 58.
    Mills M, Wofsy CB, Mills J. The acquired immunodeficiency Syndrome: infection control and public health law. N Engl J Med 1986; 314: 931–936.PubMedCrossRefGoogle Scholar
  61. 59.
    Centers for Disease Control. Classification system for human T- lymphotrophic virus type III/lymphadenopathy-associated virus infections. MMWR 1986; 35 (20): 334–339.Google Scholar
  62. 60.
    Shannon KM, Ammann AJ. Acquired immune deficiency Syndrome in children. J Pediatr 1985; 106: 332–342.PubMedCrossRefGoogle Scholar
  63. 61.
    Francis DP, Jaffe HW, Fultz PN, et al. The natural history of infection with the lymphadenopathy-associated virus Human T- lymphotropic virus type III. Ann Intern Med 1985; 103: 719–722.PubMedCrossRefGoogle Scholar
  64. 62.
    Centers for Disease Control. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR 1985;34: 682–686, 691–695.Google Scholar
  65. 63.
    Goldsmith MF. Medical news: many groups offer AIDS information, support. JAMA 1985; 254: 2522–2523.PubMedCrossRefGoogle Scholar
  66. 64.
    Redfield RR, Markham PD, Salahuddin SZ, et al. Frequent transmission of HTLV-III among spouses of patients with AIDS-re-lated complex and AIDS. JAMA 1985; 253: 1571–1573.PubMedCrossRefGoogle Scholar
  67. 65.
    Centers for Disease Control. Immunization of children infected with human T-lymphotrophic virus type III/lymphadenopathy-as-sociated virus. JAMA 1986; 256: 2658, 2662.Google Scholar
  68. 66.
    Dilley JW, Ochitill HN, Perl M, Volberding PA. Findings in Psychiatric consultations with patients with acquired immune deficiency Syndrome. Am J Psychiatry 1985; 142: 82–86.PubMedGoogle Scholar
  69. 67.
    Morin SF, Batchelor WF. Responding to the psychological crisis of AIDS. Public Health Rep 1984; 99 (l): 4–9.PubMedGoogle Scholar
  70. 68.
    Wolcott DL, Fawzy FI, Pasnau RO. Acquired immune deficiency Syndrome (AIDS) and consultation-liason psychiatry. Gen Hosp Psychiatry 1985; 7: 280–292.PubMedCrossRefGoogle Scholar
  71. 69.
    Billings JA. Outpatient management of advanced cancer. New York: Lippincott, 1985.Google Scholar
  72. 70.
    Rosner F, Shapiro S, Bernabo L, Howard F. Psychosocial care team for patients with AIDS in a municipal hospital (letter). JAMA 1985; 253: 2361.Google Scholar
  73. 71.
    Lockey RF, Bukantz SC. Allergie emergencies. Med Clin North Am 1974; 58: 147–156.PubMedGoogle Scholar
  74. 72.
    Clausen RW. Insect stings. J Fam Pract 1982; 15: 969–976.PubMedGoogle Scholar
  75. 73.
    Pauli BR. Imported fire ant allergy: perspectives on diagnosis and treatment. Postgrad Med 1984; 76 (1): 155–160.Google Scholar
  76. 74.
    National Institutes of Allergy and Infectious Diseases. NIH con-sensus development conference on emergency treatment of insect sting allergy. J Allergy Clin Immunol 1979; 63: 77–79.CrossRefGoogle Scholar
  77. 75.
    Frazier CA. Insect stings—a medical emergency. JAMA 1976; 235: 2410–2411.PubMedCrossRefGoogle Scholar
  78. 76.
    Yunginger JW. The sting—revisited. J Allergy Clin Immunol 1979; 64: 1–2.PubMedCrossRefGoogle Scholar
  79. 77.
    Buckley RH, Metcalfe D. Food allergy. JAMA 1982, 248: 2627–2631.Google Scholar
  80. 78.
    Schaumburg HH, Byck R, Gerstl R, et al. Monosodium L-gluta-mate: its pharmacology and role in the Chinese Restaurant Syndrome. Science 1969; 163: 826–828.PubMedCrossRefGoogle Scholar
  81. 79.
    Mattes JA, Gittelman R. Effects of artificial food colorings in children with hyperactive symptoms. Arch Gen Psychiatry 1981; 38: 714–718.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Robert D. Gillette
  • James V. Lustig

There are no affiliations available

Personalised recommendations